HRP20200145T1 - Spojevi i metode za poboljšavanje transfera virusnog gena u humane hematopoetske stanice - Google Patents

Spojevi i metode za poboljšavanje transfera virusnog gena u humane hematopoetske stanice

Info

Publication number
HRP20200145T1
HRP20200145T1 HRP20200145TT HRP20200145T HRP20200145T1 HR P20200145 T1 HRP20200145 T1 HR P20200145T1 HR P20200145T T HRP20200145T T HR P20200145TT HR P20200145 T HRP20200145 T HR P20200145T HR P20200145 T1 HRP20200145 T1 HR P20200145T1
Authority
HR
Croatia
Prior art keywords
compounds
methods
gene transfer
hematopoietic cells
viral gene
Prior art date
Application number
HRP20200145TT
Other languages
English (en)
Inventor
Guy Sauvageau
Keith Richard HUMPHRIES
Hans-Peter Kiem
Iman FARES
Jalila CHAGRAOUI
Original Assignee
Université de Montréal
British Columbia Cancer Agency Branch
Fred Hutchinson Cancer Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université de Montréal, British Columbia Cancer Agency Branch, Fred Hutchinson Cancer Research Center filed Critical Université de Montréal
Publication of HRP20200145T1 publication Critical patent/HRP20200145T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
HRP20200145TT 2014-09-18 2020-01-30 Spojevi i metode za poboljšavanje transfera virusnog gena u humane hematopoetske stanice HRP20200145T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462052452P 2014-09-18 2014-09-18
EP15841193.4A EP3194602B1 (en) 2014-09-18 2015-09-17 Compounds and methods for enhancing viral gene transfer to human hematopoietic cells
PCT/CA2015/050907 WO2016041080A1 (en) 2014-09-18 2015-09-17 Compounds and methods for enhancing viral gene transfer to human hematopoietic cells

Publications (1)

Publication Number Publication Date
HRP20200145T1 true HRP20200145T1 (hr) 2020-05-15

Family

ID=55532390

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20200145TT HRP20200145T1 (hr) 2014-09-18 2020-01-30 Spojevi i metode za poboljšavanje transfera virusnog gena u humane hematopoetske stanice

Country Status (13)

Country Link
US (1) US10273503B2 (hr)
EP (1) EP3194602B1 (hr)
JP (1) JP6795493B2 (hr)
CN (1) CN107208111B (hr)
CA (1) CA2961535C (hr)
DK (1) DK3194602T3 (hr)
ES (1) ES2773892T3 (hr)
HR (1) HRP20200145T1 (hr)
HU (1) HUE048042T2 (hr)
LT (1) LT3194602T (hr)
PL (1) PL3194602T3 (hr)
PT (1) PT3194602T (hr)
WO (1) WO2016041080A1 (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190345450A1 (en) * 2016-06-17 2019-11-14 Fred Hutchinson Cancer Research Center Strategies to assess and/or produce cell populations with predictive engraftment potential
WO2018140791A1 (en) * 2017-01-27 2018-08-02 Children's Hospital Medical Center Methods of enhancing engraftment activity of hematopoietic stem cells
WO2023286088A1 (en) * 2021-07-16 2023-01-19 Indian Institute Of Science Education And Research Bhopal Methods and compositions for viral vector transduction

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO941126D0 (no) * 1994-03-25 1994-03-25 Int Digital Tech Inc Multidomenes bevegelsesestimator
US5686278A (en) * 1994-03-25 1997-11-11 Indiana University Foundation Methods for enhanced retrovirus-mediated gene transfer
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
ATE314461T1 (de) * 1998-02-05 2006-01-15 Novartis Pharma Gmbh Vermehrte und genetisch modifizierte populationen menschlicher hämatopoitischer stammzellen
US20030044978A1 (en) 1998-02-05 2003-03-06 Novartis Corporation Expanded and genetically modified populations of human hematopoietic stem cells
GB2390090A (en) * 2002-06-24 2003-12-31 Bayer Ag Pharmaceutically active 6-carbamoylpyrimido[4,5-b]indoles
JP4343708B2 (ja) * 2002-04-26 2009-10-14 アンスティテュ ナシナル ドゥ ラ サントゥ エ ドゥ ラ ルシェルシェ メディカル−イ．エヌ．エス．ウ．エール．エム． 改良型キメラ糖タンパク質と、類型化されたレンチウイルス
WO2004058764A1 (en) * 2002-12-27 2004-07-15 Bayer Healthcare Ag 4-phenyl-pyrimido [4,5-b] indole derivatives
US20100040600A1 (en) 2006-06-14 2010-02-18 Chugai Seiyaku Kabushiki Kaisha Agents for Promoting the Growth of Hematopoietic Stem Cells
WO2008136656A1 (en) * 2007-05-02 2008-11-13 Erasmus University Medical Center Rotterdam Improved methods and means for lentiviral gene delivery
WO2009004329A1 (en) * 2007-07-02 2009-01-08 Cancer Research Technology Limited 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h-1,3,6,9-tetraaza-fluorenes as chk1 kinase function inhibitors
WO2011056739A1 (en) * 2009-11-03 2011-05-12 Glaxosmithkline Llc Compounds and methods
RU2618864C2 (ru) * 2011-09-29 2017-05-11 Энститю Насьональ Де Ля Сантэ Э Дэ Ля Решерш Медикаль (Инсерм) ЛЕНТИВИРУСНЫЕ ВЕКТОРЫ, ПСЕВДОТИПИРОВАННЫЕ МУТАНТНЫМИ BaEV ГЛИКОПРОТЕИНАМИ
WO2013110198A1 (en) * 2012-01-27 2013-08-01 Université de Montréal Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
WO2014026110A2 (en) 2012-08-10 2014-02-13 Bluebird Bio, Inc. Compounds for improved viral transduction
US10647718B2 (en) 2014-04-22 2020-05-12 Universitéde Montréal Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells

Also Published As

Publication number Publication date
DK3194602T3 (da) 2020-02-17
HUE048042T2 (hu) 2020-05-28
LT3194602T (lt) 2020-05-11
US10273503B2 (en) 2019-04-30
ES2773892T3 (es) 2020-07-15
CN107208111A (zh) 2017-09-26
US20180201953A1 (en) 2018-07-19
CN107208111B (zh) 2021-07-06
PT3194602T (pt) 2020-03-03
PL3194602T3 (pl) 2020-07-27
CA2961535A1 (en) 2016-03-24
WO2016041080A1 (en) 2016-03-24
CA2961535C (en) 2024-03-12
JP2017529075A (ja) 2017-10-05
EP3194602B1 (en) 2019-11-06
EP3194602A4 (en) 2017-10-18
EP3194602A1 (en) 2017-07-26
JP6795493B2 (ja) 2020-12-02

Similar Documents

Publication Publication Date Title
HK1250330A1 (zh) 通過核酸接種增強car-工程化的t細胞的作用
SG11201703493SA (en) Cell culture insert
ZA201606198B (en) Special handling of low priority cells
IL247460A0 (en) Cells reject viruses and their uses
IL252114A0 (en) A bioreactor using macroalgae
SG10202005898PA (en) Cell culture medium
EP3119896A4 (en) Stable gene transfer to proliferating cells
SG11201800694QA (en) Cell culture container
HK1245132A1 (zh) 改善細胞治療的方法
EP3201319A4 (en) Uses of trehalose in cell suspensions
PT3766582T (pt) Cultura de células
HRP20200145T1 (hr) Spojevi i metode za poboljšavanje transfera virusnog gena u humane hematopoetske stanice
IL247890A0 (en) Methods related to stem cells
PL3132020T3 (pl) Naczynie do hodowli komórek i jego zastosowanie
EP3126500A4 (en) Dna aptamers specific to cd200r1 and their therapeutic uses
PT3191106T (pt) Composição compreendendo uma microalga enriquecida em silício para uma utilização terapêutica
GB201416078D0 (en) Cell culture substrate
GB201421342D0 (en) Cell culture
AU2014901004A0 (en) Stable gene transfer to proliferating cells